VPAC2 Antibodies

Santa Cruz Biotechnology features a diverse variety of VPAC2 monoclonal antibodies for research focused on understanding vasoactive intestinal peptide receptor 2 (VPAC2). VPAC2 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). VPAC2 plays essential roles in numerous physiological processes, including the regulation of circadian rhythms, modulation of neurotransmitter release, and the control of smooth muscle contraction. The significance of VPAC2 in neurobiology and gastrointestinal function makes it a key target for research into various diseases, including metabolic disorders and neurodegenerative conditions. Understanding VPAC2 interactions and signaling pathways can provide insights into potential therapeutic strategies. Researchers worldwide rely on VPAC2 monoclonal antibodies to explore cellular mechanisms and pathways. VPAC2 monoclonal antibodies enable detailed investigation of protein expression, localization, and function across diverse experimental conditions. Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing scientific understanding and developing innovative therapeutic approaches.